Free Trial

Black Diamond Therapeutics (BDTX) Earnings Date, Estimates & Call Transcripts

Black Diamond Therapeutics logo
$1.56 -0.02 (-0.95%)
As of 11:14 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Black Diamond Therapeutics Earnings Summary

Upcoming
Earnings Date
May. 8Before Market OpensEstimated
Consensus EPS
(Mar. 6)
-$0.31
Actual EPS
(Mar. 6)
-$0.28 Beat By $0.03

Black Diamond Therapeutics announced Q4 2024 earnings on March 6, 2025, reporting an EPS of -$0.28, which topped analysts' consensus estimates of -$0.31 by $0.03. With a trailing EPS of -$1.27, Black Diamond Therapeutics' earnings are expected to grow next year, from ($1.30) to ($1.22) per share.

Q4 2024 Earnings Resources

BDTX Upcoming Earnings

Black Diamond Therapeutics' Q1 2025 earnings is scheduled for Thursday, May 8, 2025, with a conference call scheduled at 7:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get Black Diamond Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Black Diamond Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BDTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Black Diamond Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$0.32$0.92$0.30
Q2 20252-$0.33-$0.22-$0.28
Q3 20252-$0.33-$0.22-$0.28
Q4 20252-$0.34-$0.18-$0.26
FY 20258-$1.32$0.30-$0.51
Q1 20261-$0.22-$0.22-$0.22
Q2 20261-$0.23-$0.23-$0.23
Q3 20261-$0.23-$0.23-$0.23
Q4 20261-$0.24-$0.24-$0.24
FY 20264($0.92)($0.92)($0.92)

Black Diamond Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/8/2025
(Estimated)
-------
3/6/2025Q4 2024-$0.31-$0.28+$0.03-$0.28--
11/5/2024--$0.37-$0.28+$0.09-$0.28--
8/6/2024Q2 2024-$0.39-$0.36+$0.03-$0.36--
5/9/2024Q1 2024-$0.44-$0.35+$0.09-$0.35--
3/12/2024Q4 2023-$0.47-$0.34+$0.13-$0.34--
11/6/2023Q3 2023-$0.49-$0.45+$0.04-$0.45--
8/11/2023Q2 2023-$0.54-$0.52+$0.02-$0.52--
5/9/2023Q1 2023-$0.61-$0.57+$0.04-$0.57--

Black Diamond Therapeutics Earnings - Frequently Asked Questions

Black Diamond Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on BDTX's earnings history.

In the previous quarter, Black Diamond Therapeutics (NASDAQ:BDTX) reported ($0.28) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.31) by $0.03. Learn more on analysts' earnings estimate vs. BDTX's actual earnings.

Black Diamond Therapeutics (NASDAQ:BDTX) has a recorded net income of -$82.44 million. BDTX has generated -$1.27 earnings per share over the last four quarters.

Black Diamond Therapeutics's earnings are expected to grow from ($1.30) per share to ($1.22) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:BDTX) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners